Gingival and mandibular metastases from rectal adenocarcinoma: Case report and 20 year review of the English literature
Rentschler RE, Thrasher TV. Gingival and mandibular metastases from rectal adenocarcinoma: case report and 20 year review of the English literature. Laryngoscope 1982;92:795-797.
The use of monoclonal anti-CEA antibody immunohistochemistry in detecting the origin of oral cavity metastasis
Nitzan DW, Livni N, Marmary Y, Ben-Baruch N, SeIa J, Catane R. The use of monoclonal anti-CEA antibody immunohistochemistry in detecting the origin of oral cavity metastasis. Int J Oral Maxillofac Surg 1990;19: 162-164.
XELOX (capecitabine plus oxaliplatin): Active first-line therapy for patients with metastatic colorectal cancer
Cassidy J, Tabernero J, Twelves C, et al. XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer. J Clin Oncol 2004;22:2084-2091.
A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer
Goldberg RM, Sargent DJ, Morton RF, et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 2004; 22:23-30.
Combined liver radiation and chemotherapy for palliation of hepatic metastases from colorectal cancer
Mohiuddin M, Chen E, Ahmad N. Combined liver radiation and chemotherapy for palliation of hepatic metastases from colorectal cancer. J Clin Oncol 1996;14:722-728.